Home Lengo Therapeutics

Lengo Therapeutics

acquired
Series A
Cancer Drug Developer
Basic
Enterprise Profile

Basic Information

Lengo Therapeutics is a biopharmaceutical company focused on the discovery and development of cancer treatments. Lengo is committed to identifying several cancer mutations that existing therapies have not addressed well, helping doctors and pharmaceutical companies target driver mutations in oncology.
Lengo Therapeutics Inc.
SanDiego,California,United States of America
less than 15 people
February 14, 2019
info@lengotx.com

Enterprise Profile

Industrial Sector
New Drug Development Biological Drug Production
Technology
Biotechnology
Concept
Tumor Therapeutic Products
Application Scenarios
Biologics Innovative Drugs